Scheme in BRCA1/2 mutation carriers and controls - The Impact study. App1006349 Priority Driven Collaborative Cancer Research Scheme Priority Driven (PDCCRS) 2010: A phase III Collaborative Cancer University of randomised trial of Cancer $561,000 09/02/2011 36 Parkville 3010 Australia Melbourne postmastectomy chest wall Research irradiation in intermediate risk Scheme operable breast cancer. App1004707. CA-A1011/15 Priority-driven 2010 PdCCRS: Targeting of Collaborative Cancer The Australian two Aspects of Metabolism Cancer $546,165.40 14/02/2011 36 Canberra ACT 200 Australia National University (TOTAM) for cancer therapy. Research App1008861 Scheme Priority-driven 2010 PdCCRS: Identification Collaborative Cancer University of New of anti-apoptotic signalling Cancer $49,500.00 15/02/2011 12 Sydney NSW 2052 Australia South Wales pathways in malignant Research gliomas. App1010484 Scheme Priority-driven 2010 PdCCRS: Role of dietary Collaborative Cancer University of New compounds on PGC-1 alpha Cancer - 15/02/2011 36 Sydney NSW 2052 Australia South Wales methylation in colorectal Research cancer. App1010361 Scheme Priority-driven 2010 PdCCRS: Targeting drug Collaborative resistant genes in brain Cancer University of New Cancer cancer: delivery of siRNA to $49,500.00 15/02/2011 19 Sydney NSW 2052 Australia South Wales Research improve cancer therapy. Scheme App1003650 Priority-driven Autofluorescence imaging for Collaborative early detection and surgical Cancer University of Cancer margin delineation of oral $558,131.20 21/02/2011 44 St Lucia, QLD 4072 Australia Queensland Research cancers and pre-cancers. Scheme App1009996 Priority-driven Collaborative Cancer University of The role of CD123 in MDSA Cancer $316,276.40 24/02/2011 36 North Terrace, SA 5005 Australia Adelaide and AML. App1010336 Research Scheme
Scheme in BRCA1/2 mutation carriers and controls - The Impact study. App1006349 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2010: A phase III randomised trial of postmastectomy chest wall irradiation in intermediate risk operable breast cancer. App1004707. CA-A1011/15 $561,000 09/02/2011 36 Parkville 3010 Cancer Australia Priority-driven Collaborative Cancer Research Scheme The Australian National University 2010 PdCCRS: Targeting of two Aspects of Metabolism (TOTAM) for cancer therapy. App1008861 $546,165.40 14/02/2011 36 Canberra ACT 200 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of New South Wales 2010 PdCCRS: Identification of anti-apoptotic signalling pathways in malignant gliomas. App1010484 $49,500.00 15/02/2011 12 Sydney NSW 2052 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of New South Wales 2010 PdCCRS: Role of dietary compounds on PGC-1 alpha methylation in colorectal cancer. App1010361 - 15/02/2011 36 Sydney NSW 2052 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of New South Wales 2010 PdCCRS: Targeting drug resistant genes in brain cancer: delivery of siRNA to improve cancer therapy. App1003650 $49,500.00 15/02/2011 19 Sydney NSW 2052 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Queensland Autofluorescence imaging for early detection and surgical margin delineation of oral cancers and pre-cancers. App1009996 $558,131.20 21/02/2011 44 St Lucia, QLD 4072 Cancer Australia Priority-driven Collaborative Cancer Research Scheme University of Adelaide The role of CD123 in MDSA and AML. App1010336 $316,276.40 24/02/2011 36 North Terrace, SA 5005
grants_reporting_20170922.docx